- Home
- PIII vs HBIO Comparison
PIII vs HBIO Comparison
Compare PIII & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- HBIO
- Stock Information
- Founded
- PIII 2015
- HBIO 1901
- Country
- PIII United States
- HBIO United States
- Employees
- PIII N/A
- HBIO N/A
- Industry
- PIII Medical/Nursing Services
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- PIII Health Care
- HBIO Industrials
- Exchange
- PIII Nasdaq
- HBIO Nasdaq
- Market Cap
- PIII 20.8M
- HBIO 24.6M
- IPO Year
- PIII N/A
- HBIO 2000
- Fundamental
- Price
- PIII $7.27
- HBIO $0.56
- Analyst Decision
- PIII Buy
- HBIO Buy
- Analyst Count
- PIII 2
- HBIO 2
- Target Price
- PIII $16.25
- HBIO $3.00
- AVG Volume (30 Days)
- PIII 4.7K
- HBIO 1.4M
- Earning Date
- PIII 08-06-2025
- HBIO 08-11-2025
- Dividend Yield
- PIII N/A
- HBIO N/A
- EPS Growth
- PIII N/A
- HBIO N/A
- EPS
- PIII N/A
- HBIO N/A
- Revenue
- PIII $1,485,192,000.00
- HBIO $91,397,000.00
- Revenue This Year
- PIII N/A
- HBIO N/A
- Revenue Next Year
- PIII $7.92
- HBIO $9.75
- P/E Ratio
- PIII N/A
- HBIO N/A
- Revenue Growth
- PIII 9.79
- HBIO N/A
- 52 Week Low
- PIII $6.00
- HBIO $0.28
- 52 Week High
- PIII $32.54
- HBIO $3.45
- Technical
- Relative Strength Index (RSI)
- PIII 62.71
- HBIO 64.20
- Support Level
- PIII $6.30
- HBIO $0.39
- Resistance Level
- PIII $7.51
- HBIO $0.64
- Average True Range (ATR)
- PIII 0.36
- HBIO 0.04
- MACD
- PIII 0.15
- HBIO 0.01
- Stochastic Oscillator
- PIII 84.11
- HBIO 69.88
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.